2666 — Genertec Universal Medical Co Balance Sheet
0.000.00%
- HK$11.41bn
- HK$70.07bn
- CNY13.66bn
- 54
- 94
- 75
- 90
Annual balance sheet for Genertec Universal Medical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 2,037 | 2,396 | 2,855 | 2,906 | 2,381 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 18,863 | 21,049 | 23,997 | 26,245 | 29,179 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 21,833 | 25,042 | 28,161 | 30,695 | 33,075 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3,110 | 3,334 | 4,975 | 5,553 | 7,627 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 61,511 | 69,966 | 76,980 | 80,345 | 86,032 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 23,320 | 18,791 | 26,462 | 30,073 | 28,618 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 49,088 | 55,201 | 61,340 | 62,995 | 67,179 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 12,423 | 14,765 | 15,641 | 17,350 | 18,854 |
| Total Liabilities & Shareholders' Equity | 61,511 | 69,966 | 76,980 | 80,345 | 86,032 |
| Total Common Shares Outstanding |